✦ LIBER ✦

Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Children Aged 6 to 17 Years

✍ Scribed by Howard Trachtman; James W. Hainer; Jennifer Sugg; Renli Teng; Jonathan M. Sorof; Jerilynn Radcliffe; Candesartan in Children with Hypertension (CINCH) Investigators

Book ID: 114898630
Publisher: Le Jacq Communications, Inc.
Year: 2008
Tongue: English
Weight: 317 KB
Volume: 10
Category: Article
ISSN: 1524-6175
DOI: 10.1111/j.1751-7176.2008.00022.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long term efficacy, safety, and tolerabi

Long term efficacy, safety, and tolerability of candesartan cilexetil added to hydrochlorothiazide in patients with severe systemic hypertension

✍ Suzanne Oparil; EricL. Michelson 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

Effectiveness and Safety of Valsartan in

Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension

✍ Thomas Wells; Jeffrey Blumer; Kevin E.C. Meyers; Jose P.R. Neto; Rejane Meneses; 📂 Article 📅 2011 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 270 KB

Efficacy and Safety of Extended Release

Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience

✍ Donald L. Batisky; Jonathan M. Sorof; Jennifer Sugg; Michaelene Llewellyn; Micha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Efficacy of live attenuated influenza va

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age

✍ Robert B. Belshe; Seth L. Toback; Tingting Yi; Christopher S. Ambrose 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 108 KB

H54 Efficacy and safety of candesartan c

H54 Efficacy and safety of candesartan cilexetil in combination with hydrochlorothiazide (HCTZ) in the treatment of patients with mild to moderate hypertension unresponsive to HCTZ alone

✍ P.F. Plouin; E. Reti; S.G. Magin 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

A double-blind, placebo-controlled, dose

A double-blind, placebo-controlled, dose escalation safety, and efficacy study of ziac in patients, ages 6–17 years, with hypertension

✍ R.J. Cunningham; E.M. Urbina; R.J. Hogg; J.M. Sorof; M. Moxey-Mimms; M.A. Eissa 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB